🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

37 results for “Biocryst” Clear

  1. forodesine hydrochloride (BCX-1777)

    Biocryst

    Leukemia, T-Cell

    phase 2 small molecule completed

    1 trial

  2. forodesine hydrochloride (BCX-1777)

    Biocryst

    Leukemia, Lymphocytic, Chronic

    phase 2 small molecule completed

    1 trial

  3. forodesine hydrochloride (BCX-1777)

    Biocryst

    B-cell Acute Lymphoblastic Leukemia

    phase 2 small molecule completed

    1 trial

  4. ulodesine

    Biocryst

    Gout

    phase 2 small molecule completed

    1 trial

  5. BCX10013

    Biocryst

    Paroxysmal Nocturnal Hemoglobinuria

    phase 1 small molecule completed

    1 trial

  6. BCX17725

    Biocryst

    Netherton Syndrome

    phase 1 small molecule active

    1 trial

  7. BCX4430

    Biocryst

    Filovirus Infections

    phase 1 small molecule completed

    1 trial

  8. BCX7353 and probes

    Biocryst

    Hereditary Angioedema

    phase 1 small molecule completed

    1 trial

  9. Galidesivir

    Biocryst

    COVID-19

    phase 1 small molecule terminated

    1 trial

  10. Peldesine

    Biocryst

    HIV Infections

    phase 1 small molecule completed

    1 trial

  11. avoralstat

    Biocryst

    Diabetic Macular Edema (DME)

    phase 1 small molecule terminated

    1 trial

  12. forodesine hydrochloride

    Biocryst

    Cancer

    phase 1 small molecule completed

    1 trial

  13. galidesivir

    Biocryst

    Marburg Virus Disease

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources